Literature DB >> 27613946

Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study.

Christi A Patten1, Carrie A Bronars2, Kristin S Vickers Douglas2, Michael H Ussher3, James A Levine4, Susannah J Tye5, Christine A Hughes2, Tabetha A Brockman2, Paul A Decker6, Ramona S DeJesus2, Mark D Williams2, Thomas P Olson7, Matthew M Clark2, Angela M Dieterich5.   

Abstract

INTRODUCTION: Few studies have evaluated exercise interventions for smokers with depression or other psychiatric comorbidities. This pilot study evaluated the potential role of supervised vigorous exercise as a smoking cessation intervention for depressed females.
METHODS: Thirty adult women with moderate-severe depressive symptoms were enrolled and randomly assigned to 12 weeks of thrice weekly, in person sessions of vigorous intensity supervised exercise at a YMCA setting (EX; n = 15) or health education (HE; n = 15). All participants received behavioral smoking cessation counseling and nicotine patch therapy. Assessments were done in person at baseline, at the end of 12 weeks of treatment, and at 6 months post-target quit date. Primary end points were exercise adherence (proportion of 36 sessions attended) and biochemically confirmed 7-day point prevalence abstinence at Week 12. Biomarkers of inflammation were explored for differences between treatment groups and between women who smoked and those abstinent at Week 12.
RESULTS: Treatment adherence was high for both groups (72% for EX and 66% for HE; p = .55). The Week 12 smoking abstinence rate was higher for EX than HE (11/15 [73%] vs. 5/15 [33%]; p = .028), but no significant differences emerged at 6-month follow-up. Interleukin-6 levels increased more for those smoking than women abstinent at Week 12 (p = .040).
CONCLUSIONS: Vigorous intensity supervised exercise is feasible and enhances short-term smoking cessation among depressed female smokers. Innovative and cost-effective strategies to bolster long-term exercise adherence and smoking cessation need evaluation in this population. Inflammatory biomarkers could be examined in future research as mediators of treatment efficacy. IMPLICATIONS: This preliminary study found that vigorous intensity supervised exercise is feasible and enhances short-term smoking cessation among depressed female smokers. This research addressed an important gap in the field. Despite decades of research examining exercise interventions for smoking cessation, few studies were done among depressed smokers or those with comorbid psychiatric disorders. A novel finding was increases in levels of a pro-inflammatory biomarker observed among women who smoked at the end of the intervention compared to those who did not.
© The Author 2016. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2016        PMID: 27613946      PMCID: PMC5157716          DOI: 10.1093/ntr/ntw208

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  75 in total

1.  Biochemical verification of tobacco use and cessation.

Authors: 
Journal:  Nicotine Tob Res       Date:  2002-05       Impact factor: 4.244

2.  Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium.

Authors:  Albert J Bellg; Belinda Borrelli; Barbara Resnick; Jacki Hecht; Daryl Sharp Minicucci; Marcia Ory; Gbenga Ogedegbe; Denise Orwig; Denise Ernst; Susan Czajkowski
Journal:  Health Psychol       Date:  2004-09       Impact factor: 4.267

3.  Beneficial health effects of exercise--the role of IL-6 as a myokine.

Authors:  Bente K Pedersen; Christian P Fischer
Journal:  Trends Pharmacol Sci       Date:  2007-02-28       Impact factor: 14.819

4.  From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases.

Authors:  Susan M Czajkowski; Lynda H Powell; Nancy Adler; Sylvie Naar-King; Kim D Reynolds; Christine M Hunter; Barbara Laraia; Deborah H Olster; Frank M Perna; Janey C Peterson; Elissa Epel; Josephine E Boyington; Mary E Charlson
Journal:  Health Psychol       Date:  2015-02-02       Impact factor: 4.267

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Development and validation of a Rasch-derived CES-D short form.

Authors:  Jason C Cole; Adele S Rabin; Tom L Smith; Alan S Kaufman
Journal:  Psychol Assess       Date:  2004-12

7.  Exercise treatment for depression: efficacy and dose response.

Authors:  Andrea L Dunn; Madhukar H Trivedi; James B Kampert; Camillia G Clark; Heather O Chambliss
Journal:  Am J Prev Med       Date:  2005-01       Impact factor: 5.043

8.  Increasing fitness is associated with fewer depressive symptoms during successful smoking abstinence among women.

Authors:  David M Williams
Journal:  Int J Fit       Date:  2008-01-01

9.  Physical activity as a strategy for maintaining tobacco abstinence: a randomized trial.

Authors:  Judith J Prochaska; Sharon M Hall; Gary Humfleet; Ricardo F Munoz; Victor Reus; Julie Gorecki; Dixie Hu
Journal:  Prev Med       Date:  2008-05-16       Impact factor: 4.018

10.  Measures of abstinence in clinical trials: issues and recommendations.

Authors:  John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

View more
  19 in total

1.  Exercise or saccharin during abstinence block estrus-induced increases in nicotine-seeking.

Authors:  Wendy J Lynch; Lillian Tan; Syeda Narmeen; Rebecca Beiter; Darlene H Brunzell
Journal:  Physiol Behav       Date:  2017-10-31

Review 2.  Therapeutic efficacy of environmental enrichment for substance use disorders.

Authors:  Ewa Galaj; Eddy D Barrera; Robert Ranaldi
Journal:  Pharmacol Biochem Behav       Date:  2019-11-26       Impact factor: 3.533

3.  Self-reported leisure time exercise change during smoking cessation in men and women.

Authors:  Katherine Harrison; Nicole Noyes; Samantha Friedrichsen; Nicole Tosun; Abayomi Oyenuga; Sharon Allen
Journal:  Addict Behav       Date:  2019-06-13       Impact factor: 3.913

4.  The effect of aerobic exercises of different intensities on anxiety, cigarette addiction, sleep quality, and quality of life in former smokers.

Authors:  Ahmet Sarıtoy; Serkan Usgu
Journal:  Ir J Med Sci       Date:  2022-06-20       Impact factor: 1.568

5.  Add-on exercise interventions for smoking cessation in people with mental illness: a systematic review and meta-analysis.

Authors:  Stefanie E Schöttl; Martin Niedermeier; Prisca Kopp-Wilfling; Anika Frühauf; Carina S Bichler; Monika Edlinger; Bernhard Holzner; Martin Kopp
Journal:  BMC Sports Sci Med Rehabil       Date:  2022-06-21

6.  Feasibility of a support person intervention to promote smoking cessation treatment use among smokers with mental illness.

Authors:  Kelly A Aschbrenner; Christi A Patten; Mary F Brunette
Journal:  Transl Behav Med       Date:  2018-09-08       Impact factor: 3.046

7.  The Role of Physical Activity Enjoyment on the Acute Mood Experience of Exercise among Smokers with Elevated Depressive Symptoms.

Authors:  Ana M Abrantes; Samantha G Farris; Sarah L Garnaat; Alexia Minto; Richard A Brown; Lawrence H Price; Lisa A Uebelacker
Journal:  Ment Health Phys Act       Date:  2017-02-10

8.  Exercise as a Sex-Specific Treatment for Substance Use Disorder.

Authors:  Wendy J Lynch; Jean Abel; Andrea M Robinson; Mark A Smith
Journal:  Curr Addict Rep       Date:  2017-10-23

9.  Exercise interventions for smoking cessation.

Authors:  Michael H Ussher; Guy E J Faulkner; Kathryn Angus; Jamie Hartmann-Boyce; Adrian H Taylor
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

10.  Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Bosun Hong; Jonathan Livingstone-Banks; Hannah Wheat; Thomas R Fanshawe
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.